Skip to main navigation Skip to search Skip to main content

Cost-utility analysis of on demand rabeprazole and esomeprazole for symptomatic gastro oesophageal reflux disease

    Research output: Contribution to journalArticlepeer-review

    Original languageEnglish
    Pages (from-to)613
    JournalValue in Health
    Volume6
    Issue number6
    Publication statusPublished - 1 Nov 2003

    Cite this